Dickson Data is back at it. On Thursday it released a new infographic [below] showing which drug patents are set to expire in 2017. It follows the template of its popular 2016 infographic, which ...

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in a recent Executive Order. The 340B Drug Pricing Program has received a lot ...

In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused them of being far more likely to violate 340B Drug Pricing Program rules. In ...

Listen with Speechify 0:00 1:00 By Edyta Zielinska Please download the Adobe Flash Player to view this content: Diverting a Diet Drug The Good Fat The Future of the FDA The Trouble with Tech Transfer ...

Workforce substance abuse is on the rise, driven by an increase an illicit drug use, according to a Quest Diagnostics report. The report analyzed 10 million workforce urine test results. The company ...

There’s nothing more depressing or comical than drug commercials. After promising us a better life–vacations by pools, hugs from spouses, and plenty of golden retrievers–we’re hit with a long list of ...

The United States is in the throes of a heroin and opiate epidemic with cheap supply pushing user numbers to a 20-year high. In 2014, the number of heroin users across the U.S. reached one million, ...

America's drug crisis is getting worse. According to newly published figures from the Centers for Disease Control and Prevention, there were 70,237 deaths from drug overdoses across the United States ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

For our Spotlight on patient-derived in vitro cell models, we surveyed our audience to find out the latest trends, opinions and behaviors in the field. This infographic summarizes the results from the ...

Among the first cancer drug combinations were mixtures of several chemotherapies that resulted in better and longer-lasting responses than individual drugs could deliver. Then came targeted therapies ...

New approach methodologies (NAMs) – such as organoids, spheroids and microfluidic chip systems – aim to streamline early-stage drug discovery and revolutionize preclinical testing by augmenting ...